BUMETANIDE

BUMETANIDE was reported 26836 times

BUMETANIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 64 0.1147
1 IMMUNISATION 49 0.1129
2 BODY TINEA 55 0.0982
3 PALMOPLANTAR KERATODERMA 64 0.0883
4 CHRONIC LEFT VENTRICULAR FAILURE 28 0.0778
5 DEVICE WIRELESS COMMUNICATION ISSUE 19 0.0734
6 DEVICE MAINTENANCE ISSUE 37 0.0629
7 VENOUS PRESSURE JUGULAR INCREASED 18 0.0496
8 NEPHROGENIC ANAEMIA 229 0.0494
9 HYPERPARATHYROIDISM SECONDARY 112 0.0447
10 HYPERVOLAEMIA 188 0.0380
11 ATRIAL TACHYCARDIA 73 0.0347
12 DYSPNOEA PAROXYSMAL NOCTURNAL 25 0.0343
13 INHIBITORY DRUG INTERACTION 53 0.0335
14 CARDIORENAL SYNDROME 18 0.0314
15 RIGHT VENTRICULAR FAILURE 200 0.0285
16 ACUTE LEFT VENTRICULAR FAILURE 19 0.0283
17 CATHETER SITE DISCHARGE 31 0.0276
18 PRURITUS GENITAL 65 0.0276
19 CATHETER SITE PRURITUS 24 0.0273
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 29 0.0273
21 COR PULMONALE 26 0.0272
22 INFECTION SUSCEPTIBILITY INCREASED 58 0.0265
23 INFUSION SITE HAEMORRHAGE 87 0.0264
24 DEVICE INFUSION ISSUE 64 0.0258
25 ORTHOPNOEA 82 0.0257
26 CARDIAC AMYLOIDOSIS 28 0.0254
27 INFUSION SITE DISCHARGE 44 0.0251
28 INFUSION SITE INFECTION 57 0.0245
29 OXYGEN CONSUMPTION INCREASED 57 0.0238
30 BRASH SYNDROME 33 0.0235
31 REBOUND ACID HYPERSECRETION 71 0.0234
32 END STAGE RENAL DISEASE 423 0.0232
33 CHRONIC RESPIRATORY FAILURE 26 0.0215
34 DILATED CARDIOMYOPATHY 21 0.0208
35 CARDIOACTIVE DRUG LEVEL INCREASED 27 0.0205
36 CARDIAC FAILURE ACUTE 132 0.0198
37 LEFT ATRIAL DILATATION 25 0.0196
38 CAROTID ARTERY OCCLUSION 70 0.0192
39 LEFT VENTRICULAR FAILURE 65 0.0189
40 PULMONARY HYPERTENSION 392 0.0188
41 INFUSION SITE NODULE 18 0.0187
42 INFUSION SITE IRRITATION 24 0.0187
43 CATHETER SITE ERYTHEMA 40 0.0187
44 PULMONARY ARTERIAL HYPERTENSION 266 0.0183
45 FLUID OVERLOAD 266 0.0183
46 TENSION HEADACHE 78 0.0181
47 INFUSION SITE PAIN 225 0.0174
48 CARDIAC FAILURE CHRONIC 72 0.0169
49 ISCHAEMIC CARDIOMYOPATHY 51 0.0166
50 LOBAR PNEUMONIA 30 0.0162
51 PACKED RED BLOOD CELL TRANSFUSION 21 0.0159
52 SLEEP TERROR 66 0.0157
53 HAEMOGLOBIN INCREASED 71 0.0155
54 FLUID RETENTION 782 0.0154
55 PULMONARY ARTERIAL PRESSURE INCREASED 25 0.0153
56 INFUSION SITE ERYTHEMA 126 0.0149
57 BRAIN NATRIURETIC PEPTIDE INCREASED 46 0.0149
58 INFUSION SITE INDURATION 22 0.0148
59 ESSENTIAL HYPERTENSION 27 0.0147
60 INFUSION SITE WARMTH 18 0.0147
61 CATHETER SITE HAEMORRHAGE 35 0.0140
62 CARBON DIOXIDE INCREASED 19 0.0139
63 CATHETER SITE PAIN 34 0.0131
64 CALCIPHYLAXIS 24 0.0131
65 HAEMORRHAGIC ANAEMIA 57 0.0130
66 INFUSION SITE SWELLING 80 0.0127
67 CARDIAC FAILURE CONGESTIVE 979 0.0122
68 ECHOCARDIOGRAM ABNORMAL 17 0.0121
69 THERAPEUTIC AGENT TOXICITY 40 0.0120
70 CHRONIC KIDNEY DISEASE 907 0.0119
71 OCCULT BLOOD POSITIVE 23 0.0117
72 TRICUSPID VALVE INCOMPETENCE 91 0.0114
73 HYPOVOLAEMIA 66 0.0113
74 ACUTE KIDNEY INJURY 1711 0.0112
75 INFUSION SITE REACTION 33 0.0110
76 BLOOD POTASSIUM ABNORMAL 29 0.0109
77 BLOOD PRESSURE SYSTOLIC DECREASED 49 0.0108
78 VENTRICULAR TACHYCARDIA 177 0.0107
79 METABOLIC ENCEPHALOPATHY 32 0.0107
80 BLOOD CHLORIDE DECREASED 27 0.0105
81 ACUTE RESPIRATORY FAILURE 200 0.0104
82 DIASTOLIC DYSFUNCTION 32 0.0104
83 GLUCOSE TOLERANCE IMPAIRED 61 0.0103
84 DYSPNOEA EXERTIONAL 377 0.0100
85 DEVICE ALARM ISSUE 18 0.0099
86 BLOOD POTASSIUM INCREASED 161 0.0099
87 PURPURA 86 0.0097
88 MITRAL VALVE DISEASE 17 0.0096
89 HYPERLIPIDAEMIA 114 0.0095
90 CARDIOMEGALY 117 0.0095
91 AORTIC STENOSIS 33 0.0095
92 INTERNATIONAL NORMALISED RATIO INCREASED 268 0.0094
93 ARTERIOSCLEROSIS CORONARY ARTERY 62 0.0093
94 SEASONAL ALLERGY 132 0.0093
95 RALES 54 0.0093
96 RENAL TUBULAR NECROSIS 91 0.0093
97 CARDIAC VALVE DISEASE 53 0.0093
98 CATHETERISATION CARDIAC 41 0.0092
99 GOUT 165 0.0092
100 HYPERKALAEMIA 319 0.0091
101 DIZZINESS POSTURAL 88 0.0091
102 HEART VALVE INCOMPETENCE 26 0.0091
103 OEDEMA 492 0.0091
104 VASCULAR DEVICE INFECTION 41 0.0090
105 RENAL FAILURE ACUTE 383 0.0090
106 BLOOD BICARBONATE DECREASED 17 0.0090
107 VENTRICULAR DYSFUNCTION 23 0.0089
108 CARDIAC FAILURE 710 0.0088
109 RENAL INJURY 262 0.0088
110 ATRIAL FLUTTER 70 0.0088
111 PAIN IN JAW 246 0.0087
112 RENAL FAILURE 1142 0.0086
113 BLOOD UREA INCREASED 144 0.0086
114 IRON DEFICIENCY ANAEMIA 79 0.0085
115 INFUSION SITE PRURITUS 27 0.0085
116 GLOMERULAR FILTRATION RATE DECREASED 105 0.0085
117 HYPERNATRAEMIA 42 0.0084
118 MITRAL VALVE INCOMPETENCE 95 0.0084
119 SUBARACHNOID HAEMORRHAGE 85 0.0083
120 POLYURIA 67 0.0082
121 LEFT VENTRICULAR HYPERTROPHY 35 0.0082
122 FACIAL PAIN 73 0.0082
123 PULMONARY OEDEMA 366 0.0082
124 CONGESTIVE CARDIOMYOPATHY 34 0.0081
125 URINE OUTPUT DECREASED 71 0.0081
126 ATRIOVENTRICULAR BLOCK 62 0.0080
127 DYSPNOEA AT REST 23 0.0079
128 BREATH SOUNDS ABNORMAL 39 0.0079
129 NON-CARDIAC CHEST PAIN 25 0.0079
130 DEVICE POWER SOURCE ISSUE 23 0.0079
131 INFUSION SITE BRUISING 17 0.0079
132 LOWER GASTROINTESTINAL HAEMORRHAGE 58 0.0078
133 VASCULITIS 91 0.0078
134 DIALYSIS 110 0.0077
135 HYPOMAGNESAEMIA 107 0.0077
136 PERICARDIAL EFFUSION 177 0.0076
137 BLOOD POTASSIUM DECREASED 230 0.0076
138 HYPERCAPNIA 23 0.0076
139 CARDIAC MURMUR 66 0.0076
140 GENERALISED OEDEMA 94 0.0076
141 DIVERTICULUM INTESTINAL HAEMORRHAGIC 17 0.0076
142 HYPOXIA 266 0.0075
143 BLOOD CREATININE ABNORMAL 26 0.0075
144 LUNG CONSOLIDATION 21 0.0075
145 BLOOD LOSS ANAEMIA 17 0.0075
146 AMMONIA INCREASED 38 0.0074
147 WEIGHT BEARING DIFFICULTY 20 0.0074
148 RENAL FAILURE CHRONIC 57 0.0074
149 METHAEMOGLOBINAEMIA 17 0.0073
150 CENTRAL VENOUS CATHETERISATION 22 0.0073
151 OEDEMA PERIPHERAL 888 0.0073
152 UROSEPSIS 67 0.0073
153 TRANSFUSION 76 0.0072
154 SCLERODERMA 26 0.0071
155 ENDOTRACHEAL INTUBATION 20 0.0071
156 DERMATITIS CONTACT 81 0.0071
157 HYPOVOLAEMIC SHOCK 34 0.0071
158 LYMPHOEDEMA 49 0.0071
159 LUNG TRANSPLANT 25 0.0071
160 CELLULITIS 355 0.0070
161 AZOTAEMIA 28 0.0070
162 HAEMATOLOGICAL INFECTION 17 0.0069
163 NEPHROGENIC SYSTEMIC FIBROSIS 21 0.0069
164 OXYGEN SATURATION DECREASED 389 0.0069
165 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 17 0.0069
166 DECUBITUS ULCER 56 0.0069
167 BUNDLE BRANCH BLOCK LEFT 29 0.0068
168 TROPONIN INCREASED 52 0.0068
169 AORTIC VALVE INCOMPETENCE 29 0.0068
170 PURULENT DISCHARGE 29 0.0068
171 PROTHROMBIN TIME PROLONGED 40 0.0067
172 INTERNATIONAL NORMALISED RATIO DECREASED 27 0.0067
173 AORTIC ARTERIOSCLEROSIS 17 0.0066
174 OLIGURIA 41 0.0066
175 ASCITES 193 0.0066
176 ESCHERICHIA SEPSIS 19 0.0065
177 ORTHOSTATIC HYPOTENSION 113 0.0065
178 HAEMORRHAGIC DIATHESIS 23 0.0065
179 ATRIAL FIBRILLATION 628 0.0064
180 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 57 0.0064
181 RENAL IMPAIRMENT 541 0.0064
182 ACIDOSIS 49 0.0064
183 BLOOD CREATINE INCREASED 28 0.0063
184 EXERCISE TOLERANCE DECREASED 36 0.0062
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
186 PULSELESS ELECTRICAL ACTIVITY 26 0.0062
187 DIABETIC FOOT 19 0.0062
188 HAEMOPTYSIS 172 0.0062
189 GASTROINTESTINAL HAEMORRHAGE 515 0.0062
190 STAPHYLOCOCCAL SEPSIS 30 0.0061
191 MULTI-ORGAN FAILURE 105 0.0061
192 DRUG TOLERANCE DECREASED 17 0.0060
193 CAROTID ARTERY STENOSIS 21 0.0060
194 CARDIOGENIC SHOCK 86 0.0060
195 BLOOD CREATININE INCREASED 387 0.0059
196 ATELECTASIS 57 0.0059
197 PLEURAL EFFUSION 356 0.0058
198 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
199 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 304 0.0058
200 PERIPHERAL VASCULAR DISORDER 30 0.0058
201 INTESTINAL ISCHAEMIA 32 0.0058
202 PULMONARY CONGESTION 76 0.0058
203 TORSADE DE POINTES 45 0.0057
204 CARDIOMYOPATHY 84 0.0057
205 BLOOD MAGNESIUM DECREASED 49 0.0057
206 EJECTION FRACTION DECREASED 88 0.0057
207 WEIGHT FLUCTUATION 59 0.0056
208 IMPAIRED QUALITY OF LIFE 81 0.0056
209 PROTEIN URINE PRESENT 28 0.0056
210 EPISTAXIS 420 0.0056
211 HEART RATE ABNORMAL 31 0.0056
212 BLOOD ALBUMIN DECREASED 44 0.0055
213 RED CELL DISTRIBUTION WIDTH INCREASED 23 0.0055
214 STAPHYLOCOCCAL BACTERAEMIA 24 0.0055
215 BLOOD SODIUM DECREASED 104 0.0055
216 SPUTUM DISCOLOURED 52 0.0055
217 HYPOKALAEMIA 252 0.0055
218 DIABETIC NEUROPATHY 27 0.0054
219 HYPOTENSION 1081 0.0054
220 RENAL FUNCTION TEST ABNORMAL 25 0.0054
221 POTENTIATING DRUG INTERACTION 18 0.0054
222 HAEMODIALYSIS 45 0.0054
223 HEPATIC ENCEPHALOPATHY 50 0.0054
224 UPPER GASTROINTESTINAL HAEMORRHAGE 90 0.0053
225 HEPATIC NECROSIS 20 0.0053
226 INTERNAL HAEMORRHAGE 60 0.0052
227 CORONARY ARTERY DISEASE 159 0.0052
228 CONJUNCTIVAL HAEMORRHAGE 20 0.0052
229 MELAENA 115 0.0052
230 FAILURE TO THRIVE 27 0.0052
231 CLOSTRIDIUM DIFFICILE COLITIS 55 0.0052
232 PERIPHERAL SWELLING 799 0.0052
233 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 17 0.0051
234 SUPRAVENTRICULAR TACHYCARDIA 49 0.0051
235 SKIN ABRASION 24 0.0051
236 ENDOCARDITIS 26 0.0051
237 SINUS BRADYCARDIA 49 0.0051
238 SKIN ULCER 131 0.0051
239 SKIN LACERATION 55 0.0051
240 CARDIAC PACEMAKER INSERTION 30 0.0050
241 BLOOD URIC ACID INCREASED 29 0.0050
242 ACUTE PULMONARY OEDEMA 28 0.0050
243 SLEEP APNOEA SYNDROME 95 0.0050
244 LIVER FUNCTION TEST ABNORMAL 144 0.0049
245 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 25 0.0049
246 NEPHROPATHY 46 0.0049
247 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
248 MULTIPLE INJURIES 31 0.0049
249 VENTRICULAR ARRHYTHMIA 18 0.0049
250 DEHYDRATION 654 0.0049
251 COAGULOPATHY 81 0.0049
252 TUBULOINTERSTITIAL NEPHRITIS 91 0.0049
253 ANOSMIA 70 0.0048
254 RESPIRATORY ACIDOSIS 19 0.0048
255 POOR QUALITY SLEEP 104 0.0048
256 BRADYCARDIA 256 0.0048
257 LEUKOCYTOSIS 87 0.0048
258 DYSPNOEA 2720 0.0048
259 HYPERAMMONAEMIA 24 0.0048
260 PROTEIN TOTAL DECREASED 18 0.0048
261 CATHETER SITE INFECTION 18 0.0048
262 LUNG INFILTRATION 42 0.0048
263 ESCHERICHIA URINARY TRACT INFECTION 20 0.0047
264 RESPIRATORY FAILURE 343 0.0047
265 ECONOMIC PROBLEM 71 0.0047
266 HEPATIC CIRRHOSIS 88 0.0047
267 MENTAL STATUS CHANGES 130 0.0047
268 RECTAL HAEMORRHAGE 200 0.0047
269 HYPOCALCAEMIA 87 0.0046
270 HAEMOGLOBIN DECREASED 471 0.0046
271 PERICARDITIS 77 0.0046
272 BUNDLE BRANCH BLOCK RIGHT 21 0.0046
273 LOCALISED OEDEMA 21 0.0045
274 GASTRITIS EROSIVE 21 0.0045
275 PRODUCTIVE COUGH 215 0.0045
276 RESPIRATION ABNORMAL 31 0.0045
277 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 23 0.0045
278 PRESYNCOPE 109 0.0045
279 PRODUCT LEAKAGE 25 0.0045
280 BLOOD PRESSURE DECREASED 296 0.0045
281 HAEMATOCRIT DECREASED 88 0.0044
282 RENAL DISORDER 206 0.0044
283 DEVICE OCCLUSION 62 0.0044
284 ANHEDONIA 115 0.0044
285 DIVERTICULUM 31 0.0044
286 PRODUCT ADMINISTRATION INTERRUPTED 34 0.0043
287 DYSLIPIDAEMIA 22 0.0043
288 FAECES DISCOLOURED 92 0.0042
289 MUSCLE TWITCHING 97 0.0042
290 TRANSIENT ISCHAEMIC ATTACK 141 0.0042
291 ABDOMINAL HERNIA 19 0.0042
292 UNRESPONSIVE TO STIMULI 107 0.0041
293 UPPER-AIRWAY COUGH SYNDROME 34 0.0041
294 LEG AMPUTATION 17 0.0041
295 NEUTROPENIC SEPSIS 29 0.0041
296 FEAR 109 0.0040
297 HOSPICE CARE 40 0.0040
298 ELECTROLYTE IMBALANCE 47 0.0040
299 OBESITY 64 0.0040
300 EOSINOPHILIA 70 0.0040
301 HYPONATRAEMIA 225 0.0040
302 EMPHYSEMA 40 0.0040
303 IMPAIRED GASTRIC EMPTYING 54 0.0040
304 HAEMATOMA 102 0.0039
305 FULL BLOOD COUNT DECREASED 79 0.0039
306 THERAPY NON-RESPONDER 176 0.0039
307 ARTHRITIS INFECTIVE 18 0.0039
308 HIATUS HERNIA 50 0.0039
309 ANAEMIA 735 0.0038
310 CARDIAC OPERATION 33 0.0038
311 HAEMATURIA 131 0.0038
312 NEPHROTIC SYNDROME 26 0.0038
313 BLOOD IRON DECREASED 45 0.0038
314 VIRAL UPPER RESPIRATORY TRACT INFECTION 18 0.0038
315 VENTRICULAR FIBRILLATION 42 0.0038
316 MYOCLONUS 45 0.0038
317 VENTRICULAR EXTRASYSTOLES 39 0.0038
318 COMPRESSION FRACTURE 20 0.0037
319 SEPSIS 416 0.0037
320 DEVICE RELATED INFECTION 57 0.0037
321 ACUTE MYOCARDIAL INFARCTION 109 0.0037
322 CYANOSIS 58 0.0037
323 HAEMORRHOIDAL HAEMORRHAGE 18 0.0037
324 CORONARY ARTERY BYPASS 21 0.0036
325 INABILITY TO AFFORD MEDICATION 36 0.0036
326 DIPLOPIA 94 0.0036
327 PSEUDOMONAS INFECTION 31 0.0036
328 LIP SWELLING 120 0.0036
329 ABDOMINAL DISTENSION 376 0.0036
330 HYPOPHAGIA 92 0.0036
331 TERMINAL STATE 24 0.0036
332 PNEUMONIA 1152 0.0036
333 IMPAIRED WORK ABILITY 76 0.0036
334 TENDERNESS 37 0.0035
335 CHEST PAIN 656 0.0035
336 HEART RATE IRREGULAR 80 0.0035
337 GASTRITIS 93 0.0035
338 BLOOD PRESSURE ABNORMAL 70 0.0035
339 HYPOPHOSPHATAEMIA 26 0.0035
340 CARDIAC ARREST 289 0.0035
341 SPLENOMEGALY 41 0.0035
342 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
343 HAEMORRHAGE INTRACRANIAL 52 0.0035
344 CHOKING SENSATION 19 0.0034
345 CONFUSIONAL STATE 552 0.0034
346 LACERATION 32 0.0034
347 MALNUTRITION 38 0.0034
348 ULCER 54 0.0034
349 ANGIOPATHY 19 0.0034
350 WOUND INFECTION 37 0.0034
351 ABNORMAL LOSS OF WEIGHT 23 0.0034
352 TINNITUS 155 0.0034
353 LETHARGY 193 0.0034
354 ECCHYMOSIS 23 0.0034
355 STENT PLACEMENT 27 0.0033
356 SHOCK 77 0.0033
357 CONTUSION 322 0.0033
358 CLOSTRIDIUM DIFFICILE INFECTION 73 0.0033
359 MYOCARDIAL ISCHAEMIA 38 0.0033
360 DECREASED ACTIVITY 36 0.0033
361 ORAL HERPES 65 0.0033
362 SWELLING 311 0.0033
363 UNEVALUABLE EVENT 251 0.0033
364 FEMORAL NECK FRACTURE 17 0.0033
365 PEMPHIGOID 25 0.0033
366 LARGE INTESTINE PERFORATION 23 0.0033
367 BLOOD CALCIUM INCREASED 29 0.0033
368 COMPLICATION ASSOCIATED WITH DEVICE 48 0.0033
369 CIRCULATORY COLLAPSE 56 0.0033
370 RENAL CYST 26 0.0033
371 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
372 SYNCOPE 326 0.0033
373 HEAD INJURY 103 0.0033
374 NASAL CONGESTION 190 0.0032
375 RESPIRATORY DISTRESS 89 0.0032
376 PULMONARY MASS 48 0.0032
377 SEPTIC SHOCK 140 0.0032
378 HEPATIC CYTOLYSIS 41 0.0032
379 RASH MACULO-PAPULAR 71 0.0032
380 WEIGHT INCREASED 714 0.0032
381 LOCALISED INFECTION 77 0.0032
382 ENCEPHALOPATHY 77 0.0031
383 CARDIAC DISORDER 293 0.0031
384 COUGH 873 0.0031
385 ANGINA PECTORIS 89 0.0031
386 FAECALOMA 17 0.0031
387 CARDIAC FLUTTER 20 0.0031
388 PALPITATIONS 362 0.0031
389 BODY HEIGHT DECREASED 33 0.0031
390 URINARY TRACT INFECTION 525 0.0031
391 BLOOD BILIRUBIN INCREASED 83 0.0031
392 TUMOUR LYSIS SYNDROME 27 0.0031
393 GASTRIC ULCER HAEMORRHAGE 17 0.0031
394 RIB FRACTURE 63 0.0031
395 SKIN DISORDER 102 0.0031
396 HALLUCINATION 230 0.0030
397 HEART RATE INCREASED 300 0.0030
398 PULMONARY FIBROSIS 58 0.0030
399 CHOLECYSTITIS 36 0.0030
400 TACHYPNOEA 41 0.0030
401 ASPIRATION 33 0.0030
402 LOWER RESPIRATORY TRACT INFECTION 137 0.0030
403 HYPOGLYCAEMIA 146 0.0030
404 STAPHYLOCOCCAL INFECTION 99 0.0030
405 CHOLELITHIASIS 98 0.0030
406 FLANK PAIN 28 0.0030
407 COLITIS ISCHAEMIC 20 0.0030
408 THERAPY CHANGE 29 0.0029
409 FALL 980 0.0029
410 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
411 SINUS DISORDER 58 0.0029
412 ASTHENIA 1101 0.0029
413 KIDNEY INFECTION 57 0.0029
414 HYPERBILIRUBINAEMIA 30 0.0029
415 GASTROOESOPHAGEAL REFLUX DISEASE 233 0.0029
416 AORTIC ANEURYSM 22 0.0029
417 PAIN OF SKIN 77 0.0029
418 CORONARY ARTERY OCCLUSION 39 0.0028
419 GASTRIC ULCER 54 0.0028
420 HAEMATEMESIS 72 0.0028
421 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 22 0.0028
422 EYE PRURITUS 95 0.0028
423 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0028
424 HAEMOGLOBIN ABNORMAL 18 0.0028
425 LIMB INJURY 76 0.0028
426 BLINDNESS 114 0.0028
427 SUBDURAL HAEMATOMA 40 0.0028
428 GASTRIC HAEMORRHAGE 32 0.0028
429 LOSS OF CONSCIOUSNESS 356 0.0028
430 ANGINA UNSTABLE 18 0.0028
431 RESPIRATORY TRACT CONGESTION 44 0.0028
432 ARTERIOSCLEROSIS 26 0.0028
433 SCIATICA 44 0.0028
434 POST PROCEDURAL HAEMORRHAGE 32 0.0027
435 BRONCHITIS 203 0.0027
436 SINUS CONGESTION 37 0.0027
437 LIGAMENT SPRAIN 27 0.0027
438 COLD SWEAT 48 0.0027
439 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
440 INJURY 190 0.0027
441 BACTERAEMIA 32 0.0027
442 VITAMIN D DECREASED 23 0.0027
443 HEART RATE DECREASED 94 0.0027
444 LUNG DISORDER 131 0.0027
445 BLOOD CALCIUM DECREASED 30 0.0027
446 DIZZINESS 1330 0.0027
447 POLLAKIURIA 111 0.0027
448 DRUG INTERACTION 422 0.0027
449 LABORATORY TEST ABNORMAL 78 0.0026
450 RESPIRATORY SYNCYTIAL VIRUS INFECTION 23 0.0026
451 INSURANCE ISSUE 40 0.0026
452 TACHYCARDIA 232 0.0026
453 LIPASE INCREASED 20 0.0026
454 CARDIO-RESPIRATORY ARREST 109 0.0026
455 CYSTITIS 83 0.0026
456 SINUS TACHYCARDIA 37 0.0026
457 GASTROENTERITIS VIRAL 47 0.0026
458 DECREASED APPETITE 602 0.0026
459 PETECHIAE 27 0.0026
460 THROMBOCYTOPENIA 289 0.0026
461 THERAPY PARTIAL RESPONDER 40 0.0026
462 MYOCARDIAL INFARCTION 447 0.0026
463 WEIGHT DECREASED 715 0.0026
464 PERITONITIS 53 0.0026
465 ANURIA 22 0.0026
466 ARRHYTHMIA 121 0.0026
467 POST PROCEDURAL COMPLICATION 49 0.0025
468 MULTIPLE ALLERGIES 20 0.0025
469 HYPERSOMNIA 73 0.0025
470 CANDIDA INFECTION 43 0.0025
471 PULMONARY TOXICITY 18 0.0025
472 BLOOD PRESSURE FLUCTUATION 61 0.0025
473 DIARRHOEA 1628 0.0025
474 STEVENS-JOHNSON SYNDROME 56 0.0025
475 WHEEZING 149 0.0025
476 METABOLIC ACIDOSIS 80 0.0025
477 BACK PAIN 581 0.0025
478 DIVERTICULITIS 69 0.0025
479 LIMB DISCOMFORT 77 0.0025
480 DEVICE PHYSICAL PROPERTY ISSUE 19 0.0025
481 OESOPHAGITIS 27 0.0025
482 CHEST DISCOMFORT 253 0.0025
483 CATARACT 147 0.0025
484 NEURALGIA 60 0.0025
485 THIRST 44 0.0025
486 FULL BLOOD COUNT ABNORMAL 26 0.0025
487 SCAB 28 0.0025
488 WHITE BLOOD CELL COUNT INCREASED 94 0.0024
489 HYPOALBUMINAEMIA 19 0.0024
490 HEPATOMEGALY 24 0.0024
491 ESCHERICHIA INFECTION 20 0.0024
492 RASH MACULAR 85 0.0024
493 RESTLESS LEGS SYNDROME 44 0.0024
494 PANCYTOPENIA 135 0.0024
495 DEAFNESS 63 0.0024
496 THROAT IRRITATION 108 0.0024
497 HAND FRACTURE 17 0.0024
498 PNEUMOTHORAX 38 0.0024
499 ANGIOEDEMA 106 0.0024
500 INCREASED TENDENCY TO BRUISE 22 0.0024
501 SPINAL OSTEOARTHRITIS 21 0.0024
502 CONSTIPATION 521 0.0024
503 HYPERCHOLESTEROLAEMIA 23 0.0024
504 RESPIRATORY TRACT INFECTION 62 0.0024
505 BLOOD COUNT ABNORMAL 36 0.0024
506 AMNESIA 154 0.0024
507 DYSURIA 87 0.0024
508 HEPATIC STEATOSIS 44 0.0024
509 BLOOD GLUCOSE DECREASED 113 0.0024
510 DISORIENTATION 93 0.0023
511 PLATELET COUNT DECREASED 250 0.0023
512 MUSCULAR WEAKNESS 266 0.0023
513 RESPIRATORY DISORDER 70 0.0023
514 TREATMENT NONCOMPLIANCE 128 0.0023
515 ANAL INCONTINENCE 21 0.0023
516 HIP FRACTURE 75 0.0023
517 HOSPITALISATION 357 0.0023
518 OSTEOMYELITIS 42 0.0023
519 RED BLOOD CELL COUNT DECREASED 66 0.0023
520 HAEMORRHOIDS 45 0.0023
521 SKIN DISCOLOURATION 106 0.0023
522 UPPER RESPIRATORY TRACT INFECTION 106 0.0023
523 SKIN HAEMORRHAGE 34 0.0023
524 DYSPHONIA 134 0.0023
525 PNEUMONIA BACTERIAL 21 0.0023
526 EMBOLISM 19 0.0023
527 FATIGUE 1780 0.0023
528 HYPERTHYROIDISM 33 0.0023
529 URINARY RETENTION 76 0.0023
530 HERNIA 44 0.0023
531 HYPOTHERMIA 23 0.0023
532 HYDRONEPHROSIS 17 0.0023
533 HYPERCALCAEMIA 28 0.0023
534 MUSCULOSKELETAL CHEST PAIN 35 0.0023
535 ROTATOR CUFF SYNDROME 29 0.0023
536 DELIRIUM 78 0.0022
537 AGEUSIA 56 0.0022
538 HAEMORRHAGE 234 0.0022
539 LOWER LIMB FRACTURE 43 0.0022
540 BONE DENSITY DECREASED 70 0.0022
541 BRAIN FOG 35 0.0022
542 DEVICE FAILURE 34 0.0022
543 RASH PAPULAR 50 0.0022
544 RHABDOMYOLYSIS 93 0.0022
545 MYALGIA 379 0.0022
546 DYSPEPSIA 219 0.0022
547 NOCTURIA 27 0.0022
548 WOUND 62 0.0022
549 FOOT FRACTURE 42 0.0022
550 BLISTER 124 0.0022
551 COVID-19 PNEUMONIA 26 0.0022
552 HYPERGLYCAEMIA 80 0.0022
553 GALLBLADDER DISORDER 39 0.0022
554 SPINAL COMPRESSION FRACTURE 18 0.0022
555 SUDDEN DEATH 23 0.0022
556 TASTE DISORDER 44 0.0022
557 DRY THROAT 22 0.0022
558 BALANCE DISORDER 187 0.0022
559 COGNITIVE DISORDER 101 0.0022
560 LACTIC ACIDOSIS 70 0.0022
561 TOOTH ABSCESS 22 0.0022
562 URINARY INCONTINENCE 64 0.0022
563 RETCHING 46 0.0022
564 THERAPY INTERRUPTED 154 0.0022
565 NEUTROPHIL COUNT INCREASED 22 0.0021
566 BACTERIAL INFECTION 40 0.0021
567 SKIN INFECTION 24 0.0021
568 BLOOD TEST ABNORMAL 30 0.0021
569 ORAL CANDIDIASIS 28 0.0021
570 HERPES ZOSTER 122 0.0021
571 ARTHRITIS 167 0.0021
572 CONTRAINDICATED PRODUCT ADMINISTERED 64 0.0021
573 SMALL INTESTINAL OBSTRUCTION 26 0.0021
574 ABDOMINAL DISCOMFORT 354 0.0021
575 DEEP VEIN THROMBOSIS 137 0.0021
576 JOINT INJURY 45 0.0021
577 FLUSHING 214 0.0021
578 MICTURITION URGENCY 24 0.0021
579 DRUG DISPENSING ERROR 32 0.0021
580 CONDITION AGGRAVATED 635 0.0021
581 INCONTINENCE 22 0.0021
582 HEADACHE 1301 0.0021
583 UNINTENTIONAL MEDICAL DEVICE REMOVAL 24 0.0021
584 CARPAL TUNNEL SYNDROME 29 0.0021
585 TOOTH DISORDER 46 0.0021
586 HYPOTHYROIDISM 66 0.0021
587 THROMBOSIS 166 0.0021
588 PNEUMONITIS 56 0.0021
589 OSTEOARTHRITIS 87 0.0021
590 GROIN PAIN 18 0.0020
591 FEELING COLD 57 0.0020
592 DEVICE DISLOCATION 89 0.0020
593 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 21 0.0020
594 PHARYNGEAL SWELLING 20 0.0020
595 ILLNESS 210 0.0020
596 DRY MOUTH 165 0.0020
597 MEDICATION ERROR 113 0.0020
598 BRONCHOSPASM 29 0.0020
599 DRUG ERUPTION 36 0.0020
600 EYE HAEMORRHAGE 27 0.0020
601 PAIN IN EXTREMITY 595 0.0020
602 HAEMATOCHEZIA 111 0.0020
603 ANXIETY 572 0.0020
604 DEATH 1731 0.0020
605 GASTROINTESTINAL INFECTION 18 0.0020
606 MYELODYSPLASTIC SYNDROME 29 0.0020
607 NECK PAIN 112 0.0020
608 ANKLE FRACTURE 31 0.0020
609 NAUSEA 1585 0.0020
610 MALAISE 877 0.0020
611 HYPERTENSION 423 0.0020
612 RHINORRHOEA 129 0.0020
613 SCRATCH 21 0.0020
614 GASTROENTERITIS 29 0.0020
615 DRUG TOXICITY 27 0.0020
616 PERITONITIS BACTERIAL 20 0.0020
617 FEELING ABNORMAL 474 0.0020
618 ACUTE HEPATIC FAILURE 27 0.0020
619 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
620 MUSCULOSKELETAL DISCOMFORT 34 0.0020
621 MUSCLE TIGHTNESS 32 0.0020
622 VOMITING 922 0.0020
623 RESPIRATORY ARREST 54 0.0020
624 ABDOMINAL PAIN UPPER 403 0.0020
625 BLOOD GLUCOSE INCREASED 368 0.0020
626 LOCAL SWELLING 34 0.0019
627 BLOOD URINE PRESENT 37 0.0019
628 VITAMIN D DEFICIENCY 19 0.0019
629 DISTURBANCE IN ATTENTION 105 0.0019
630 GAIT INABILITY 65 0.0019
631 ABASIA 48 0.0019
632 PRODUCT DISTRIBUTION ISSUE 18 0.0019
633 NEUROPATHY PERIPHERAL 184 0.0019
634 APPENDICITIS 18 0.0019
635 MACULAR DEGENERATION 23 0.0019
636 PULMONARY EMBOLISM 183 0.0019
637 MOBILITY DECREASED 138 0.0019
638 PLATELET COUNT INCREASED 25 0.0019
639 PALLOR 52 0.0019
640 THERAPY CESSATION 98 0.0019
641 BACK DISORDER 31 0.0019
642 HYPOACUSIS 82 0.0019
643 DEMENTIA 53 0.0019
644 BLOOD GLUCOSE ABNORMAL 35 0.0019
645 MUSCLE ATROPHY 24 0.0019
646 DIABETES MELLITUS 144 0.0019
647 SWOLLEN TONGUE 59 0.0019
648 INSOMNIA 503 0.0019
649 CONJUNCTIVITIS 35 0.0019
650 NO THERAPEUTIC RESPONSE 23 0.0019
651 IMMUNODEFICIENCY 28 0.0019
652 LIVER DISORDER 83 0.0019
653 PLASMA CELL MYELOMA 73 0.0019
654 INTESTINAL PERFORATION 21 0.0019
655 OCULAR DISCOMFORT 21 0.0019
656 SCAR 32 0.0019
657 ELECTROCARDIOGRAM QT PROLONGED 67 0.0019
658 FUNGAL INFECTION 62 0.0019
659 UPPER LIMB FRACTURE 37 0.0019
660 PHARYNGITIS 23 0.0019
661 TREMOR 307 0.0018
662 SPINAL FRACTURE 37 0.0018
663 MIGRAINE 176 0.0018
664 TYPE 2 DIABETES MELLITUS 62 0.0018
665 PROTEINURIA 35 0.0018
666 PRODUCT USE COMPLAINT 29 0.0018
667 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
668 SECRETION DISCHARGE 23 0.0018
669 IMPAIRED HEALING 60 0.0018
670 PANCREATITIS ACUTE 41 0.0018
671 JAUNDICE 49 0.0018
672 TOOTH INFECTION 24 0.0018
673 DRUG LEVEL INCREASED 30 0.0018
674 PHOTOPHOBIA 34 0.0018
675 MEMORY IMPAIRMENT 248 0.0018
676 PNEUMONIA ASPIRATION 45 0.0018
677 INCORRECT PRODUCT ADMINISTRATION DURATION 39 0.0018
678 CHILLS 211 0.0018
679 HALLUCINATION, VISUAL 38 0.0018
680 GAIT DISTURBANCE 344 0.0018
681 HEPATIC FAILURE 54 0.0018
682 VISUAL IMPAIRMENT 221 0.0018
683 BREAST PAIN 19 0.0018
684 RASH PRURITIC 96 0.0018
685 HEREDITARY ANGIOEDEMA 19 0.0018
686 ACTIVITIES OF DAILY LIVING IMPAIRED 35 0.0018
687 MANIA 29 0.0018
688 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
689 WRIST FRACTURE 21 0.0018
690 PAIN 1071 0.0017
691 VIRAL INFECTION 58 0.0017
692 PROSTATIC SPECIFIC ANTIGEN INCREASED 24 0.0017
693 JOINT SWELLING 210 0.0017
694 DYSPHAGIA 165 0.0017
695 BLOOD GLUCOSE FLUCTUATION 19 0.0017
696 NERVOUSNESS 90 0.0017
697 INTENTIONAL DOSE OMISSION 49 0.0017
698 MUSCLE SPASMS 313 0.0017
699 INFLUENZA 190 0.0017
700 GENERAL PHYSICAL HEALTH DETERIORATION 197 0.0017
701 HYPERHIDROSIS 219 0.0017
702 ORAL PAIN 38 0.0017
703 BURNING SENSATION 119 0.0017
704 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
705 ASPARTATE AMINOTRANSFERASE INCREASED 90 0.0017
706 DEPRESSED LEVEL OF CONSCIOUSNESS 67 0.0017
707 FLATULENCE 95 0.0017
708 LUNG INFECTION 26 0.0017
709 DISEASE PROGRESSION 198 0.0017
710 ARTHRALGIA 695 0.0017
711 COVID-19 293 0.0017
712 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
713 MUSCULOSKELETAL PAIN 87 0.0017
714 RASH GENERALISED 43 0.0017
715 DEVICE LEAKAGE 72 0.0017
716 ABDOMINAL PAIN 386 0.0017
717 EAR DISCOMFORT 17 0.0017
718 PHARMACEUTICAL PRODUCT COMPLAINT 43 0.0017
719 INTENTIONAL PRODUCT USE ISSUE 145 0.0017
720 PULMONARY THROMBOSIS 18 0.0016
721 APHONIA 23 0.0016
722 BONE PAIN 96 0.0016
723 VISION BLURRED 225 0.0016
724 DENTAL CARIES 18 0.0016
725 FEEDING DISORDER 33 0.0016
726 INTESTINAL OBSTRUCTION 61 0.0016
727 SEROTONIN SYNDROME 31 0.0016
728 OROPHARYNGEAL PAIN 149 0.0016
729 JOINT DISLOCATION 17 0.0016
730 DYSKINESIA 65 0.0016
731 SOMNOLENCE 322 0.0016
732 SWELLING FACE 104 0.0016
733 GASTROINTESTINAL DISORDER 143 0.0016
734 INFECTION 231 0.0016
735 BONE DISORDER 29 0.0016
736 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 76 0.0016
737 SKIN CANCER 34 0.0016
738 PRODUCT DOSE OMISSION 103 0.0016
739 BONE MARROW FAILURE 32 0.0016
740 BLINDNESS UNILATERAL 22 0.0016
741 THYROID DISORDER 24 0.0016
742 ANOREXIA 20 0.0016
743 EAR PAIN 30 0.0015
744 METASTASES TO LIVER 27 0.0015
745 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
746 PANCREATITIS 81 0.0015
747 SINUSITIS 157 0.0015
748 ASTHMA 173 0.0015
749 PERIPHERAL COLDNESS 21 0.0015
750 PRURITUS GENERALISED 33 0.0015
751 HYPOAESTHESIA ORAL 23 0.0015
752 HEAD DISCOMFORT 27 0.0015
753 HEPATITIS 39 0.0015
754 PRURITUS 582 0.0015
755 GLAUCOMA 29 0.0015
756 EATING DISORDER 32 0.0015
757 PHARYNGEAL OEDEMA 23 0.0015
758 INJECTION SITE IRRITATION 19 0.0015
759 RASH ERYTHEMATOUS 71 0.0015
760 HEMIPARESIS 25 0.0015
761 PYREXIA 510 0.0015
762 PRODUCT PRESCRIBING ERROR 35 0.0015
763 FEELING JITTERY 28 0.0015
764 DEPRESSION 334 0.0015
765 EAR INFECTION 39 0.0015
766 NEPHROLITHIASIS 67 0.0015
767 PRESCRIBED UNDERDOSE 29 0.0015
768 EYE PAIN 82 0.0015
769 JOINT STIFFNESS 38 0.0014
770 ILEUS 18 0.0014
771 TOOTH EXTRACTION 18 0.0014
772 DYSSTASIA 42 0.0014
773 PRODUCT ADMINISTRATION ERROR 29 0.0014
774 ROAD TRAFFIC ACCIDENT 60 0.0014
775 CEREBRAL INFARCTION 35 0.0014
776 CEREBROVASCULAR ACCIDENT 242 0.0014
777 INTENTIONAL PRODUCT MISUSE 125 0.0014
778 SNEEZING 32 0.0014
779 GLYCOSYLATED HAEMOGLOBIN INCREASED 36 0.0014
780 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
781 SLEEP DISORDER 100 0.0014
782 BLOOD PRESSURE INCREASED 216 0.0014
783 BURSITIS 17 0.0014
784 PRODUCT DOSE OMISSION ISSUE 411 0.0014
785 ERUCTATION 27 0.0014
786 DRY SKIN 186 0.0014
787 NASOPHARYNGITIS 256 0.0014
788 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
789 INTERSTITIAL LUNG DISEASE 67 0.0014
790 TOOTHACHE 25 0.0014
791 PRODUCT PRESCRIBING ISSUE 30 0.0014
792 CHROMATURIA 31 0.0014
793 BODY TEMPERATURE INCREASED 28 0.0014
794 MUSCULOSKELETAL DISORDER 26 0.0014
795 IMMUNE SYSTEM DISORDER 18 0.0014
796 FACE OEDEMA 23 0.0014
797 TENDONITIS 21 0.0014
798 SPEECH DISORDER 71 0.0014
799 HOT FLUSH 102 0.0014
800 C-REACTIVE PROTEIN INCREASED 49 0.0013
801 DRUG INTOLERANCE 130 0.0013
802 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
803 NIGHT SWEATS 43 0.0013
804 SICKLE CELL ANAEMIA WITH CRISIS 21 0.0013
805 MOUTH ULCERATION 28 0.0013
806 DYSARTHRIA 50 0.0013
807 LACRIMATION INCREASED 40 0.0013
808 ABSCESS 21 0.0013
809 SKIN LESION 36 0.0013
810 GASTRIC DISORDER 45 0.0013
811 RASH 570 0.0013
812 CHOLESTASIS 25 0.0013
813 BEDRIDDEN 17 0.0013
814 COLITIS 49 0.0013
815 PANIC ATTACK 47 0.0013
816 OSTEOPOROSIS 53 0.0013
817 KNEE ARTHROPLASTY 27 0.0013
818 LYMPHADENOPATHY 45 0.0013
819 JOINT RANGE OF MOTION DECREASED 17 0.0013
820 IRRITABLE BOWEL SYNDROME 27 0.0013
821 THROAT TIGHTNESS 34 0.0013
822 CEREBRAL HAEMORRHAGE 45 0.0013
823 INCREASED APPETITE 24 0.0013
824 EMOTIONAL DISTRESS 152 0.0013
825 OSTEOPENIA 19 0.0013
826 MOVEMENT DISORDER 40 0.0012
827 PRODUCT USE ISSUE 234 0.0012
828 GINGIVAL BLEEDING 17 0.0012
829 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
830 CHOKING 24 0.0012
831 FEMUR FRACTURE 38 0.0012
832 PROCEDURAL PAIN 34 0.0012
833 COORDINATION ABNORMAL 17 0.0012
834 WHITE BLOOD CELL COUNT DECREASED 131 0.0012
835 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
836 HYPOAESTHESIA 180 0.0012
837 PSYCHOTIC DISORDER 35 0.0012
838 ALOPECIA 232 0.0012
839 SKIN EXFOLIATION 99 0.0012
840 DEPRESSED MOOD 62 0.0012
841 ERYTHEMA 241 0.0012
842 DYSGEUSIA 87 0.0012
843 HYPOKINESIA 17 0.0012
844 PARAESTHESIA 183 0.0012
845 DISABILITY 23 0.0012
846 FREQUENT BOWEL MOVEMENTS 31 0.0011
847 ABDOMINAL PAIN LOWER 29 0.0011
848 FEELING HOT 70 0.0011
849 STOMATITIS 69 0.0011
850 BLOOD CHOLESTEROL INCREASED 53 0.0011
851 APHASIA 34 0.0011
852 MIDDLE INSOMNIA 21 0.0011
853 DIABETIC KETOACIDOSIS 27 0.0011
854 INFLAMMATION 58 0.0011
855 ILL-DEFINED DISORDER 67 0.0011
856 AGITATION 81 0.0011
857 EYE SWELLING 41 0.0011
858 LYMPHOMA 17 0.0011
859 GYNAECOMASTIA 34 0.0011
860 HYPERSENSITIVITY 204 0.0011
861 PRODUCT AVAILABILITY ISSUE 25 0.0011
862 INFLUENZA LIKE ILLNESS 90 0.0011
863 DEVICE ISSUE 97 0.0011
864 EPILEPSY 33 0.0011
865 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
866 SURGERY 63 0.0011
867 MENTAL IMPAIRMENT 26 0.0011
868 LIVER FUNCTION TEST INCREASED 23 0.0011
869 ADVERSE DRUG REACTION 96 0.0011
870 DEVICE USE ERROR 37 0.0011
871 DRUG DOSE OMISSION 176 0.0011
872 EYE DISORDER 35 0.0011
873 ARTHROPATHY 59 0.0011
874 TOXICITY TO VARIOUS AGENTS 178 0.0011
875 DEVICE MALFUNCTION 74 0.0011
876 VERTIGO 64 0.0010
877 PARANOIA 18 0.0010
878 DRUG PRESCRIBING ERROR 20 0.0010
879 METASTASES TO BONE 17 0.0010
880 CARDIOVASCULAR DISORDER 26 0.0010
881 LYMPHOCYTE COUNT DECREASED 18 0.0010
882 DERMATITIS 21 0.0010
883 LEUKOPENIA 50 0.0010
884 OFF LABEL USE 875 0.0010
885 INCORRECT DRUG ADMINISTRATION DURATION 28 0.0010
886 COMPLETED SUICIDE 82 0.0010
887 PRESCRIBED OVERDOSE 19 0.0010
888 ERECTILE DYSFUNCTION 25 0.0010
889 ISCHAEMIC STROKE 17 0.0010
890 FIBROMYALGIA 23 0.0009
891 DRUG ADMINISTRATION ERROR 29 0.0009
892 CONVULSION 54 0.0009
893 PRODUCT PHYSICAL ISSUE 19 0.0009
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
895 ADVERSE EVENT 86 0.0009
896 NEUTROPHIL COUNT DECREASED 38 0.0009
897 SYSTEMIC LUPUS ERYTHEMATOSUS 33 0.0009
898 ACCIDENTAL OVERDOSE 34 0.0009
899 MUSCULOSKELETAL STIFFNESS 81 0.0009
900 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
901 DRY EYE 46 0.0009
902 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 31 0.0009
903 SEDATION 24 0.0009
904 ABNORMAL BEHAVIOUR 36 0.0009
905 DISCOMFORT 55 0.0009
906 URTICARIA 151 0.0009
907 TRANSAMINASES INCREASED 20 0.0009
908 VAGINAL HAEMORRHAGE 39 0.0009
909 MENTAL DISORDER 39 0.0009
910 NIGHTMARE 31 0.0009
911 HEPATIC ENZYME INCREASED 61 0.0009
912 EXTRA DOSE ADMINISTERED 36 0.0009
913 SEIZURE 101 0.0009
914 PRODUCT USE IN UNAPPROVED INDICATION 210 0.0008
915 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
916 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 60 0.0008
917 MOOD ALTERED 23 0.0008
918 EMOTIONAL DISORDER 26 0.0008
919 ANAPHYLACTIC REACTION 46 0.0008
920 ECZEMA 43 0.0008
921 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 148 0.0008
922 LIVER INJURY 20 0.0008
923 INJECTION SITE PRURITUS 54 0.0008
924 COMA 38 0.0008
925 UNDERDOSE 58 0.0008
926 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 157 0.0008
927 ABNORMAL DREAMS 21 0.0008
928 AGGRESSION 38 0.0008
929 VISUAL ACUITY REDUCED 25 0.0008
930 NEUTROPENIA 102 0.0007
931 FEBRILE NEUTROPENIA 49 0.0007
932 NERVOUS SYSTEM DISORDER 23 0.0007
933 INCORRECT DOSE ADMINISTERED 168 0.0007
934 EXPOSURE VIA SKIN CONTACT 19 0.0007
935 OSTEONECROSIS 24 0.0007
936 EXTRAPYRAMIDAL DISORDER 18 0.0007
937 EXPIRED PRODUCT ADMINISTERED 24 0.0007
938 NEOPLASM MALIGNANT 48 0.0007
939 NEOPLASM PROGRESSION 25 0.0007
940 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 49 0.0007
941 NEEDLE ISSUE 20 0.0007
942 LUNG NEOPLASM MALIGNANT 28 0.0007
943 ANGER 23 0.0007
944 INJECTION SITE BRUISING 54 0.0007
945 OCULAR HYPERAEMIA 32 0.0007
946 DRUG INEFFECTIVE 884 0.0007
947 MOOD SWINGS 21 0.0007
948 INJECTION SITE RASH 20 0.0007
949 INJECTION SITE HAEMORRHAGE 52 0.0007
950 DEVICE DIFFICULT TO USE 43 0.0006
951 IRRITABILITY 39 0.0006
952 INJECTION SITE ERYTHEMA 78 0.0006
953 PRODUCT QUALITY ISSUE 85 0.0006
954 EYE IRRITATION 36 0.0006
955 INJECTION SITE MASS 23 0.0006
956 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
957 CRYING 22 0.0006
958 INFUSION RELATED REACTION 39 0.0006
959 THERAPEUTIC RESPONSE DECREASED 35 0.0006
960 PSORIATIC ARTHROPATHY 23 0.0006
961 MALIGNANT NEOPLASM PROGRESSION 58 0.0006
962 RESTLESSNESS 20 0.0005
963 MULTIPLE SCLEROSIS 26 0.0005
964 OVERDOSE 117 0.0005
965 DEVICE BREAKAGE 22 0.0005
966 PRODUCT SUBSTITUTION ISSUE 31 0.0005
967 DISEASE RECURRENCE 25 0.0005
968 PSORIASIS 66 0.0005
969 SKIN IRRITATION 23 0.0005
970 RHEUMATOID ARTHRITIS 57 0.0005
971 DRUG EFFECT DECREASED 27 0.0005
972 WRONG TECHNIQUE IN DRUG USAGE PROCESS 18 0.0005
973 DRUG ABUSE 41 0.0005
974 SUICIDAL IDEATION 45 0.0005
975 INJECTION SITE PAIN 149 0.0005
976 HEPATIC FUNCTION ABNORMAL 18 0.0005
977 INJECTION SITE SWELLING 36 0.0005
978 DRUG EFFECT INCOMPLETE 17 0.0005
979 THERAPEUTIC PRODUCT EFFECT DECREASED 20 0.0004
980 NO ADVERSE EVENT 74 0.0004
981 INJECTION SITE REACTION 28 0.0004
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 19 0.0004
983 DERMATITIS ATOPIC 21 0.0004
984 SKIN BURNING SENSATION 26 0.0004
985 PROSTATE CANCER 29 0.0004
986 DRUG WITHDRAWAL SYNDROME 30 0.0003
987 MULTIPLE SCLEROSIS RELAPSE 20 0.0003
988 TREATMENT FAILURE 24 0.0003
989 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
990 PRODUCT STORAGE ERROR 23 0.0003
991 BREAST CANCER 24 0.0003
992 ACNE 19 0.0003
993 DRUG DEPENDENCE 27 0.0002